Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp360 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Osteoporosis risk factor correlation with BMD in Latvia

Pavlina Inese , Rasa Ingvars , Adamsone Inara , Daukste Ilze , Jaundzeikare Sandra , Kaneps Dainis , Kaze Ingrida , Medne Agita , Zelca Signe

Objective(s): To assess osteoporosis risk factors for postmenopausal women and correlation with bone mineral density (BMD) in Latvia.Material and methods: A national cross-sectional study conducted in Latvia about osteoporosis risk factors in postmenopausal women and BMD determination with DXA. 1.598 women who had a DXA scan visit, took part in a study (May–October 2012). The women filled out a questionnaire with 25 multiple choice questions on oste...

ba0003pp399 | Other diseases of bone and mineral metabolism | ECTS2014

Effect of vitamin D treatment on bone mineral density in deficient immigrant women

Englund Marianne , Bergstrom Ingrid

Background: The optimal level of 25-hydroxyvitamin D2 (25(OH) D) for a healthy bone is not clear, nor the effects of treatment with vitamin D. Few previous studies have measured treatment effect on BMD in young deficient individuals.Materials and methods: A treatment group of vitamin D deficient immigrant women and a control group of ethnic Swedish women were recruited during pregnancy. A treatment of 800–1600 IU cholecalciferol and 500–1000 mg...

ba0003pp385 | Other diseases of bone and mineral metabolism | ECTS2014

The effect of vitamin D treatment on pain, fatigue and muscular strength in women with vitamin D deficiency

Englund Marianne , Persson Jan , Torbjorn AEkerstedt , Bergstrom Ingrid

Objective: To find whether treatment with cholecalciferol and calcium in a group of vitamin D deficient women is associated with changes in muscular function, musculoskeletal pain, and fatigue.Design: Prospective interventional cohort study.Sample: A study group of 25 post partum women recruited and diagnosed with hypovitaminosis D during pregnancy.Setting: The study group was recruited 2006–2009 at two ...

ba0005p229 | Energy metabolism and bone, fat and bone | ECTS2016

Impaired adipose tissue inflammation results in increased bone mineral density in mice

Grahnemo Louise , Gustafsson Karin , Asterholm Wernstedt Ingrid , Lagerquist Marie

Obesity, diabetes, and high fracture risk is linked, but the mechanism is unclear. However, impaired acute adipose tissue inflammation may be a common denominator for these conditions. Impaired adipose tissue inflammation leads to low adipogenesis, insufficient adipose expansion, and signs of diabetes.The aim of this study was to investigate if the low adipogenesis induced by impaired adipose tissue inflammation is coupled to increased osteoblastogenesis...

ba0001pp135 | Cancer and bone: basic, translational and clinical | ECTS2013

Anti-RANKL nanobody ALX-0141 shows sustained biomarker inhibition in a Phase I study in healthy postmenopausal Women

Schoen Pieter , Jacobs Sandy , Verschueren Katrien , Ottevaere Ingrid , Sobry Sigrid , Holz Josefin-Beate

Introduction: The interaction between RANK/RANKL is critical for the regulation of osteoclastogenesis and bone resorption. Inhibition of this interaction helps restore the balance between bone resorption and formation. ALX-0141, a novel biological agent (Nanobody) that specifically targets RANKL, was studied in a Phase I trial to assess the safety, tolerability, immunogenicity and PK after single injection.Methods: Forty-two healthy postmenopausal women ...

ba0001pp457 | Other diseases of bone and mineral metabolism | ECTS2013

DPP4 inhibition attenuates bone loss in diabetic rats

Glorie Lorenzo , Behets Geert , Baerts Lesley , De Meester Ingrid , D'Haese Patrick , Verhulst Anja

Dipeptidyl peptidase 4 (DPP4) modulates activity of proteins by removing two aminoterminal amino acids. DPP4 inhibitors are currently being used to improve glucose tolerance in type 2 diabetes patients by increasing the half-life of DPP4 substrates. It has been shown that these substrates do not only increase pancreatic insulin secretion, but also influence bone cell activity. The potential therapeutic effect of DPP4 inhibition on bone metabolism is thus worth being investigat...

ba0002p83 | (1) | ICCBH2013

Anti-RANKL nanobody ALX-0141 shows sustained biomarker inhibition in a phase I study in healthy postmenopausal women

Schoen Pieter , Jacobs Sandy , Verschueren Katrien , Ottevaere Ingrid , Sobry Sigrid , Holz Josefin-Beate

Objectives: The interaction between RANK and its ligand RANKL is critical for the regulation of osteoclastogenesis and bone resorption. Inhibition of this interaction helps restore the balance between bone resorption and bone formation. ALX-0141, a novel biological agent (Nanobody) that specifically targets RANKL, was studied in a phase I trial to assess the safety, tolerability, immunogenicity and PK after a single s.c. injection.Methods: Forty-two heal...

ba0002p62 | (1) | ICCBH2013

The effect of the ketogenic diet on the developing skeleton

Simm Peter , Bicknell-Royle Jill , Nation Judy , Draffin Kellie , Stewart Karen , Cameron Fergus , Scheffer Ingrid , Mackay Mark

Objectives: The ketogenic diet (KD) is a medically supervised, high fat, low carbohydrate and restricted protein diet which has been used successfully in patients with refractory epilepsy. Only one published report has explored its effect on the skeleton. We postulated that KD impairs bone mass accrual and examined skeletal health parameters in this patient group.Methods: Patients commenced on the KD from 2002–2009 were enrolled in a prospective, lo...

ba0005p247 | Genetics and Epigenetics | ECTS2016

Common variants in Rspo 1,2 and 3 do not associate with BMD in stratified subpopulations of the Odense Androgen Study and mutations in these genes are not a common cause of craniotubular hyperostosis

Fijalkowski Igor , Hendrickx Gretl , Boudin Eveline , Szilagyi Ingrid , Nielsen Torben , Andersen Marianne , Brixen Kim , Van Hul Wim

The R-spondins are a family of four small, secreted agonists of the Wnt signaling pathway. Growing evidence from both in vitro studies and in vivo models supports the major role of these proteins in the skeletal development processes. In humans, common genetic variation in the RSPO3 gene has been associated with BMD in large scale GWAS study.This study aimed at further investigation of the genetic and functional contributions of the R-s...